Deutsche Bank’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Deutsche Bank’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-781,435	Closed	-$537K	–	4818
2020 Q4	$537K	Sell	781,435 -71,410	-8%	-$152K	﹤0.01%	2859
2020 Q3	$1.92M	Sell	852,845 -35,757	-4%	-$102K	﹤0.01%	1768
2020 Q2	$3.18M	Sell	888,602 -13,002	-1%	-$46.9K	﹤0.01%	1535
2020 Q1	$3.43M	Buy	901,604 +334,451	+59%	+$1.1M	﹤0.01%	1447
2019 Q4	$1.7M	Buy	+567,153	New	+$1.47M	﹤0.01%	2066

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $77B AUM 10.33% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

WAM

Westport Asset Management Southport, Connecticut $245M AUM 15.03% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Deutsche Bank's BMY.RT Position: Q1 2021 in Review

Deutsche Bank sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 781,435 shares — an estimated $537K sold.

Deutsche Bank first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $3.43M in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

Deutsche Bank reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
Deutsche Bank sold 781,435 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $537K.
Deutsche Bank first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
Deutsche Bank's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $3.43M in Q1 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Deutsche Bank's 13F filing for Q1 2021, filed 13 May 2021.